ZONE

135th Canton Fair Showcases Revolutionary Home Furnishing Innovations

Retrieved on: 
Mercredi, avril 24, 2024
Generation Z, Household goods, Fair, AI, Furniture, Research, Shenzhen, Canton Fair, ZONE, Sleep

GUANGZHOU, China, April 24, 2024 /PRNewswire/ -- The second phase of the eagerly anticipated 135th China Import and Export Fair ( "Canton Fair", or "the Fair"), lasting 5 days, kicked off on April 23rd, spotlighting Housewares, Gifts & Decorations, Building & Furniture.

Key Points: 
  • GUANGZHOU, China, April 24, 2024 /PRNewswire/ -- The second phase of the eagerly anticipated 135th China Import and Export Fair ( "Canton Fair", or "the Fair"), lasting 5 days, kicked off on April 23rd, spotlighting Housewares, Gifts & Decorations, Building & Furniture.
  • These solutions are designed to meet consumer demands for functionality and quality while aligning with current design trends.
  • Their chairs come equipped with two-position self-weight back support trays, ensuring flexibility and comfort between working or resting postures.
  • The 135th Canton Fair brings together numerous companies committed to innovation in the furniture sector aiming to create new quality living experiences for consumers worldwide.

135th Canton Fair Showcases Revolutionary Home Furnishing Innovations

Retrieved on: 
Mercredi, avril 24, 2024
Generation Z, Household goods, Fair, AI, Furniture, Research, Shenzhen, Canton Fair, ZONE, Multimedia, Sleep

GUANGZHOU, China, April 24, 2024 /PRNewswire/ -- The second phase of the eagerly anticipated 135th China Import and Export Fair ( "Canton Fair", or "the Fair"), lasting 5 days, kicked off on April 23rd, spotlighting Housewares, Gifts & Decorations, Building & Furniture.

Key Points: 
  • GUANGZHOU, China, April 24, 2024 /PRNewswire/ -- The second phase of the eagerly anticipated 135th China Import and Export Fair ( "Canton Fair", or "the Fair"), lasting 5 days, kicked off on April 23rd, spotlighting Housewares, Gifts & Decorations, Building & Furniture.
  • These solutions are designed to meet consumer demands for functionality and quality while aligning with current design trends.
  • Their chairs come equipped with two-position self-weight back support trays, ensuring flexibility and comfort between working or resting postures.
  • The 135th Canton Fair brings together numerous companies committed to innovation in the furniture sector aiming to create new quality living experiences for consumers worldwide.

Zebra Technologies Unveils Reimagined Software Portfolio at ZONE Customer Conferences

Retrieved on: 
Mardi, octobre 10, 2023
Technology, Finance, Fintech, Other Technology, Professional Services, Software, Data Management, Other Professional Services, Artificial Intelligence, Omni, Workforce, Senior, Forecasting, Intelligence, Zebra Technologies, NEC Software Solutions, Risk, ZONE, Microelectronics and Computer Technology Corporation, Workforce optimization, The ODP Corporation, Enterprise Collaboration Architecture, Inventory, Face, Management, Retail, Video game, Zebra

Zebra Technologies Corporation (NASDAQ: ZBRA), a leading digital solution provider enabling businesses to intelligently connect data, assets, and people, unveiled Zebra Workcloud™ —its purpose-built suite of enterprise software applications—at its annual ZONE customer user conferences held last month in Las Vegas, Nev. and Reading, United Kingdom.

Key Points: 
  • Zebra Technologies Corporation (NASDAQ: ZBRA), a leading digital solution provider enabling businesses to intelligently connect data, assets, and people, unveiled Zebra Workcloud™ —its purpose-built suite of enterprise software applications—at its annual ZONE customer user conferences held last month in Las Vegas, Nev. and Reading, United Kingdom.
  • Zebra Workcloud works natively with Zebra devices, and it is designed to be the destination solution for front-line worker optimization.
  • Zebra unveiled its reimagined software portfolio, Zebra Workcloud—a purpose-built suite of enterprise applications that works natively with Zebra devices—at its ZONE customer conferences held last month.
  • ZONE offers Zebra’s vibrant customer community the opportunity to connect and learn from other Zebra customers and partners, plus experience our latest hardware and software innovation like Zebra Workcloud.

Zucara Therapeutics Announces Additional Funding from JDRF to Support ZT-01 Phase 2 Study

Retrieved on: 
Jeudi, juin 15, 2023
JDRF, Insulin, National Rural Development Partnership, Diabetes, T1D, Quality of life, Research, ZONE, Doctor of Philosophy, US, Hypoglycemia, Patient, Therapy, Caregiver, Pharmaceutical industry

Through its Industry Discovery & Development Partnerships ("IDDP") program, JDRF will provide US$2 million in funding to support Zucara's planned Phase 2a study of the effect of ZT-01 On Nocturnal hypoglycemia Events in Type 1 diabetes mellitus ("ZONE").

Key Points: 
  • Through its Industry Discovery & Development Partnerships ("IDDP") program, JDRF will provide US$2 million in funding to support Zucara's planned Phase 2a study of the effect of ZT-01 On Nocturnal hypoglycemia Events in Type 1 diabetes mellitus ("ZONE").
  • Zucara expects to begin patient dosing in the third quarter of 2023.
  • "JDRF has been a long-time partner of Zucara, supporting the development of ZT-01 from early discovery studies to this planned Phase 2 study soon underway," said Richard Liggins PhD, Zucara Therapeutics' Chief Scientific Officer.
  • "JDRF is excited to support Zucara's development of a novel therapy with the potential to protect against nocturnal hypoglycemia and help people with T1D achieve better glucose control."

Zucara Therapeutics Receives IND Clearance for Phase 2 Clinical Trial of ZT-01

Retrieved on: 
Mercredi, avril 19, 2023
Insulin, Diabetes, T1D, Anxiety, Glucagon, Type 1 diabetes, ZONE, Investigational New Drug, Hypoglycemia, Patient, FDA, Therapy, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, Medical device, Pharmaceutical industry

The FDA's clearance enables Zucara to initiate its planned trial titled A Phase 2a study of effect of ZT-01 On Nocturnal hypoglycemia Events in Type 1 diabetes mellitus (ZONE), with first patient dosing expected to occur in the third quarter of 2023.

Key Points: 
  • The FDA's clearance enables Zucara to initiate its planned trial titled A Phase 2a study of effect of ZT-01 On Nocturnal hypoglycemia Events in Type 1 diabetes mellitus (ZONE), with first patient dosing expected to occur in the third quarter of 2023.
  • We are excited to take the next step in developing what could be the first therapeutic available to prevent night-time hypoglycemia."
  • Patients will self administer one of three doses of ZT-01, or placebo, every evening before bed each for a four-week period.
  • Secondary endpoints include the number of patients experiencing adverse events and time spent in hypoglycemia, compared to placebo.